Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder

被引:21
作者
Ribal, MJ
Alcaraz, A
Mengual, L
Carrio, A
Lopez-Guillermo, A
Mallofré, C
Palou, J
Gelabert, A
Villavicencio, H
机构
[1] Fundacio Puigvert, Dept Urol, Barcelona 08025, Spain
[2] Hosp Clin Barcelona, Dept Genet, Barcelona, Spain
[3] Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain
[4] Hosp Clin Barcelona, Dept Oncol, Barcelona, Spain
[5] Hosp Mar, Dept Urol, Barcelona, Spain
关键词
transitional cell carcinoma; high chromosomal polysomies; prognostic factors;
D O I
10.1016/j.eururo.2003.12.013
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The main prognostic factor generally accepted for tumour progression in T1 transitional cell carcinoma (TCC) of the bladder is histological grade. Despite this fact it is considered inaccurate to make clinical decisions on individuals. It appears that progression from minimally invasive to deeply invasive cancer is concurrent with the acquisition of genomic alterations that increase the malignant potential of cancer cells. The aim of this study is to determine if changes in chromosomes 7, 8, 9 and 17 copy number can be used to predict recurrence and progression in patients with T I TCC of the urinary bladder. Methods: Thirty-one T1 TCC samples were analyzed for chromosomal alterations by fluorescence in situ hybridization using centromeric probes for chromosomes 7, 8, 9 and 17. Clinical data were collected from the patients' clinical records and correlated with chromosomal studies. Results: Histological grade was continued as a prognostic factor of tumour progression (p = 0.01). None of the cytogenetic alterations demonstrated in the studied group could be related to tumour recurrence. The high-polysomies (five or more copies) of chromosomes 8, 9 and 17 showed predictive value (1) = 0.05, 0.05, 0.03 respectively) for tumour progression since it was observed that patients with high-polysomy of these chromosomes showed more risk of tumour progression towards muscle-invasive disease than those without high-polysomy alteration. Conclusion: Our findings suggest a possible prognostic significance of highly aneuploid cells (high-polysomies of chromosomes 8, 9 and 17) in tumour progression of T1 TCC bladder tumours. FISH analysis is a reproducible technique for evaluating cytogenetic alterations and could contribute to the assessment of the individual prognosis of T1 transitional cell carcinoma of the bladder. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:593 / 599
页数:7
相关论文
共 26 条
[1]  
Bartlett JMS, 1999, BJU INT, V84, P775
[2]  
BRAUERS A, 1999, RENAL BLADDER PROSTA
[3]   Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1 [J].
Brown, JA ;
Takahashi, S ;
Alcaraz, A ;
Borell, TJ ;
Anderl, KL ;
Qian, JQ ;
Persons, DL ;
Bostwick, DG ;
Lieber, MM ;
Jenkins, RB .
JOURNAL OF UROLOGY, 1996, 156 (01) :31-35
[4]  
Bubendorf L, 2001, AM J CLIN PATHOL, V116, P79
[5]   Numerical aberrations of chromosome 8 and allelic loss at 8p in non-muscle-invasive urothelial carcinomas of the urinary bladder [J].
Erbersdobler, A ;
Kaiser, H ;
Friedrich, MG ;
Henke, RP .
EUROPEAN UROLOGY, 2000, 38 (05) :590-596
[6]  
HOPMAN AHN, 1991, CANCER RES, V51, P644
[7]   Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumor recurrence [J].
Jung, I ;
Reeder, JE ;
Cox, C ;
Siddiqui, JFM ;
O'Connell, MJ ;
Collins, L ;
Yang, ZH ;
Messing, EM ;
Wheeless, LL .
JOURNAL OF UROLOGY, 1999, 162 (06) :1900-1903
[8]   COMPARATIVE GENOMIC HYBRIDIZATION FOR MOLECULAR CYTOGENETIC ANALYSIS OF SOLID TUMORS [J].
KALLIONIEMI, A ;
KALLIONIEMI, OP ;
SUDAR, D ;
RUTOVITZ, D ;
GRAY, JW ;
WALDMAN, F ;
PINKEL, D .
SCIENCE, 1992, 258 (5083) :818-821
[9]  
Li B, 1998, Int J Urol, V5, P317, DOI 10.1111/j.1442-2042.1998.tb00358.x
[10]   p53 expression predicts progression and poor survival in T1 bladder tumours [J].
Llopis, J ;
Alcaraz, A ;
Ribal, MJ ;
Solé, M ;
Ventura, PJ ;
Barranco, MA ;
Rodriguez, A ;
Corral, JM ;
Carretero, P .
EUROPEAN UROLOGY, 2000, 37 (06) :644-653